Skip to main content
. 2004 Nov;48(11):4485–4487. doi: 10.1128/AAC.48.11.4485-4487.2004

FIG. 1.

FIG. 1.

Drug profiles over a period of 12 h for two malaria patients (SA8 and SA30) and one healthy volunteer (SAN1) tested with the HRP2 bioassay, with an isotopic bioassay, and by HPLC-ECD. Results of both bioassays are given as nanomolar DHA activity equivalents, and HPLC-ECD results are given as cumulative concentrations of DHA and AS.